What is Crosstree?
Founded in 2004 and headquartered in Tampa, Florida, with a strategic presence in New York City, Crosstree operates as a specialized investment banking firm. The company distinguishes itself through deep domain expertise in the health science industry, providing bespoke advisory services that encompass mergers and acquisitions, recapitalization, and strategic growth financing. Unlike generalist firms, Crosstree leverages its niche focus to provide actionable insights that bridge the gap between complex medical innovation and institutional capital requirements, effectively serving as a cornerstone for firms seeking to scale their operations or restructure their balance sheets.
How much funding has Crosstree raised?
Crosstree has raised a total of $496K across 2 funding rounds:
Debt
$150K
Debt
$346K
Debt (2020): $150K with participation from PPP
Debt (2021): $346K led by PPP
Key Investors in Crosstree
PPP
Public-Private Partnership
What's next for Crosstree?
With the successful deployment of $346K, Crosstree is well-positioned to accelerate its advisory footprint across the global health science market. The firm's strategic roadmap likely involves expanding its reach into emerging biotech and medical device sectors, where the demand for sophisticated M&A guidance is currently at an all-time high. By leveraging its established reputation for excellence in recapitalization, Crosstree is poised to capitalize on the ongoing consolidation within the healthcare industry, providing the necessary financial architecture to support the next generation of life science breakthroughs. Future growth will likely be defined by the firm's ability to integrate advanced data analytics into its advisory framework, further cementing its status as a leader in health science financial services.
See full Crosstree company page
